On 15 October 2026, SAINT BELLA GP executed an on-market repurchase of 78,500 ordinary shares at prices ranging from HKD 2.66 to HKD 2.75, for a total consideration of approximately HKD 0.21 million.
Following the transaction, the company’s outstanding share capital (excluding treasury shares) decreased marginally by 0.0128% to 615.18 million shares, while treasury shares rose to 7.02 million. Total issued shares remain unchanged at 622.20 million.
The buyback forms part of a mandate approved on 30 June 2026 that authorises the company to repurchase up to 62.22 million shares. Cumulative repurchases under this mandate now stand at 7.02 million shares, or 1.13% of the share base as of the mandate date.
In accordance with Hong Kong listing rules, SAINT BELLA GP is subject to a moratorium on issuing new shares or disposing of treasury shares until 14 November 2026. The company confirmed all repurchases were conducted in compliance with the applicable regulations and its previously filed explanatory statement.
Comments